ADVERTISEMENT
FGFR References
References
- Kuemmerle JF, Barnard JA, McHugh KM. Chapter 8 - Growth Factors in the Gastrointestinal Tract. In: Johnson LR, Ghishan FK, Kaunitz JD, Merchant JL, Said HM, Wood JD, eds. Physiology of the Gastrointestinal Tract (Fifth Edition). Academic Press; 2012:199-277.
- Drafahl KA, McAndrew CW, Donoghue DJ. Chapter 237 - Signaling from Fibroblast Growth Factor Receptors in Development and Disease. In: Bradshaw RA, Dennis EA, eds. Handbook of Cell Signaling (Second Edition). Academic Press; 2010:1939-1947.
- Itoh N. Fibroblast Growth Factor (FGF)☆. In: Reference Module in Biomedical Sciences. Elsevier; 2014.
- Santolla MF, Maggiolini M. The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives. Cancers (Basel). 2020;12(10):3029.
- Gu W, Yang J, Wang Y, et al. Comprehensive identification of FGFR1-4 alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing. Am J Cancer Res. 2021;11(8):3893-3906.
- Kono M, Komatsuda H, Yamaki H, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 11(1):2021619.
- Li L, Zhang S, Li H, Chou H. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR. BMC Cancer. 2019;19(1):963.
- Chae YK, Ranganath K, Hammerman PS, et al. Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application. Oncotarget. 2016;8(9):16052-16074.
- Garje R, An J, Obeidat M, et al. Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer. Oncologist. 2020;25(11):e1711-e1719.
